Product Overview
Recombinant Vesicular Stomatitis Virus pseudotyped Angola marburgvirus glycoprotein (rVSV pseudotyped MARV-Angola GP) system in which the G protein of VSV has been deleted, replaced with firefly luciferase and used to produce VSV pseudotypes containing the envelope glycoprotein of Angola marburgvirus. Since the infectivity of rVSV pseudotyped MARV-Angola GP is restricted to a single round of replication, analyses of viral entry can be performed using just biosafety level 2 (BSL-2) containment. Infectivity and neutralization of infectivity can be measured by luciferase activity.
Alternative Names
Marburgvirus; Marburg virus; MARV-Angola GP; MARV; MARV GP; Marburg glycoprotein; MARV glycoprotein; Marburg virus glycoprotein; MARV Pseudovirus; Marburg virus Pseudovirus; Marburg Pseudovirus
Application Notes
Neutralization
Concentration
4.02E+08 RLU/ml
Buffer
DMEM, 1% FBS, L-glutamine and Penicillin/Streptomycin
Storage
Store at -80⁰C . Multiple freeze/thaw cycles not recommended.
When using the virus, transfer the virus from the -80⁰C refrigerator and melt it in an ice bath.
Antigen Description
Marburgvirus Angola Envelope Glycoprotein
Keywords
Marburgvirus; Marburg virus; MARV-Angola GP; MARV; MARV GP; Marburg glycoprotein; MARV glycoprotein; Marburg virus glycoprotein; MARV Pseudovirus; Marburg virus Pseudovirus; Marburg Pseudovirus
Citations
Publication ()
Have you cited PSVCD102 in a publication?
Let us know and earn a reward for your research.